Italian study tracks Real-World use of approved leukemia drug
NCT ID NCT06205498
Summary
This study aims to understand how well patients with chronic lymphocytic leukemia (CLL) stay on the drug acalabrutinib in everyday Italian clinics, outside of controlled trials. It will follow 151 adult patients who started the drug between May 2021 and April 2022. The main goal is to see how long patients continue treatment and to learn the reasons they might stop.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alessandria, 15121, Italy
-
Research Site
Ancona, 60126, Italy
-
Research Site
Bari, 70124, Italy
-
Research Site
Barletta, 76121, Italy
-
Research Site
Brindisi, 72100, Italy
-
Research Site
Campobasso, 86100, Italy
-
Research Site
Catania, 95100, Italy
-
Research Site
Catanzaro, 88100, Italy
-
Research Site
Cosenza, 87100, Italy
-
Research Site
Crema, 26013, Italy
-
Research Site
Cuneo, 12100, Italy
-
Research Site
Foggia, 71122, Italy
-
Research Site
Frosinone, 03100, Italy
-
Research Site
Genova, 16132, Italy
-
Research Site
Lecce, 73100, Italy
-
Research Site
Messina, 98158, Italy
-
Research Site
Milan, 20122, Italy
-
Research Site
Milan, 20132, Italy
-
Research Site
Monza, 20900, Italy
-
Research Site
Napoli, 80131, Italy
-
Research Site
Padua, 35128, Italy
-
Research Site
Pagani, 84016, Italy
-
Research Site
Perugia, 06132, Italy
-
Research Site
Pescara, 65124, Italy
-
Research Site
Ravenna, 48121, Italy
-
Research Site
Reggio Calabria, 89133, Italy
-
Research Site
Roma, 00133, Italy
-
Research Site
Roma, 00161, Italy
-
Research Site
Roma, 00168, Italy
-
Research Site
Roma, 00184, Italy
-
Research Site
Roma, 00189, Italy
-
Research Site
Rozzano, 20089, Italy
-
Research Site
Salerno, 84078, Italy
-
Research Site
San Giovanni Rotondo, 71013, Italy
-
Research Site
Torino, 10043, Italy
-
Research Site
Torino, 10073, Italy
-
Research Site
Torino, 10126, Italy
-
Research Site
Torino, 10154, Italy
-
Research Site
Tricase, 73039, Italy
-
Research Site
Varese, 21100, Italy
-
Research Site
Viterbo, 01100, Italy
Conditions
Explore the condition pages connected to this study.